PDND
Phytochemical Database for Neurological Disorders
search icon
Advanced search

Phytochemical Name : Physostigmine
PCNDIDP0103
Pubchem CID : 5983
Molecular formula: C15H21N3O2

Molecular weight : 275.350

Canonical SMILES : CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C

Synonymes : physostigmine|Eserine|57-47-6|Antilirium|Physostol|Esromiotin|(-)-physostigmine|Ezerin|Calabarine|Erserine|Fysostigmin|cogmine|(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate|Fysostigmin [Czech]|eserin|Eserinum|Eserolein, methylcarbamate (ester)|Eserine sulfate|CCRIS 3422|HSDB 3161|MCV 4484|CHEMBL94|EINECS 200-332-8|NIH 10421|NSC 30782|NSC-30782|Physostigmine [USP:BAN]|RCRA waste no. P204|Physostigmine [USAN:BAN]|UNII-9U1VM840SP|CS 58525|Methyl-carbamic acid, ester with eseroline|9U1VM840SP|Carbamic acid, methyl-, ester with eseroline|DTXSID3023471|CHEBI:27953|C15H21N3O2|MCV-4484|NSC30782|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-|NCGC00093889-03|ESERINE HEMISULFATE|[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate|1,2,3,3abeta,8abeta-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)-indol-5-yl methylcarbamate|(3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol methylcarbamate (ester)|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)|DTXCID603471|CHEMBL537674|(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate|CAS-57-47-6|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-|Eserolein, methylcarbamate|physostigmin|Xalieve|(-) physostigmine|Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-|Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-|Eserine (TN)|Physostigmine (USP)|Spectrum_000916|Spectrum_001789|ESERINUM [HPUS]|SpecPlus_000381|Prestwick0_000566|Prestwick1_000566|Prestwick2_000566|Prestwick3_000566|Spectrum2_000330|Spectrum2_000757|Spectrum2_001283|Spectrum3_000545|Spectrum3_000901|Spectrum4_000997|Spectrum4_001631|Spectrum4_001913|Spectrum5_000441|Spectrum5_000626|Spectrum5_001672|PHYSOSTIGMINE [MI]|D09JVV|physostigmine.salicylic acid|PHYSOSTIGMINE [HSDB]|Lopac0_000483|SCHEMBL24044|BSPBio_000352|BSPBio_002189|KBioGR_001433|KBioGR_002061|KBioGR_002533|KBioSS_001396|KBioSS_002279|PHYSOSTIGMINE [VANDF]|MLS001304022|DivK1c_006477|PHYSOSTIGMINE [MART.]|SPECTRUM1500753|SPBio_000339|SPBio_000774|SPBio_001285|SPBio_002571|PHYSOSTIGMINE [WHO-DD]|BPBio1_000388|cid_657348|GTPL6598|MEGxp0_001872|ACon1_000097|BDBM11023|KBio1_001421|KBio2_001396|KBio2_002278|KBio2_003964|KBio2_004846|KBio2_006532|KBio2_007414|KBio3_001689|KBio3_001842|Eserine, >=98.0% (N)|HMS1921G06|HMS2089M11|HMS2236L08|HMS3261B07|BCP19735|Carbamic acid, ester with eseroline|HY-N6608|PHYSOSTIGMINE [USP IMPURITY]|Tox21_111228|Tox21_301591|Tox21_500483|BDBM50004000|BDBM50222010|CCG-38605|MFCD00151090|AKOS016843649|Tox21_111228_1|CS-O-11713|DB00981|LP00483|SDCCGMLS-0066585.P001|SDCCGSBI-0050467.P005|NCGC00093889-01|NCGC00093889-02|NCGC00093889-04|NCGC00093889-05|NCGC00093889-06|NCGC00093889-07|NCGC00093889-08|NCGC00093889-09|NCGC00093889-10|NCGC00093889-12|NCGC00093889-13|NCGC00093889-20|NCGC00255345-01|NCGC00261168-01|AC-15983|SMR000718753|SBI-0050467.P004|LS-109562|Physostigmine (buccal, xerostomia), Calabar|CS-0034353|EU-0100483|P0406|Physostigmine (local acting gel, xerostomia)|Physostigmine 100 microg/mL in Acetonitrile|C06535|D00196|E 8375|EN300-23839407|Q410595|Acetylcholinesterase inhibitor (dry mouth), Calabar|Eserine; Antilirium; Physostol; Esromiotin; Ezerin|SR-01000075341-1|WLN: T B556 EN GNTT&J B1 E1 G1 KOVM1|BRD-K25650355-001-02-5|BRD-K25650355-059-02-3|BRD-K25650355-059-12-2|Physostigmine (local acting gel, xerostomia), Calabar|(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate hydrochloride|(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid|(3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol methylcarba-mate (ester)|1,2,3,3A.BETA.,8A.BETA.-HEXAHYDRO-1,3A,8-TRIMETHYLPYRROLO(2,3-B)-INDOL-5-YL METHYLCARBAMATE|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), (3aS,8aR)-|Pyrrolo[2, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-

Structure
3D structure 2D structure
5983
Predicted properties (NCBI Pubchem)

Physicochemical Properties